blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3864018

EP3864018 - SOLID FORMS OF N-(4-FLUORO-3-(6-(3-METHYLPYRIDIN-2-YL)-[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-2-YL)PHENYL)-2,4-DIMETHYLOXAZOLE-5-CARBOXAMIDE [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  11.02.2022
Database last updated on 25.09.2024
FormerRequest for examination was made
Status updated on  16.07.2021
FormerThe international publication has been made
Status updated on  18.04.2020
Formerunknown
Status updated on  28.10.2019
Most recent event   Tooltip02.02.2024Change - inventorpublished on 06.03.2024  [2024/10]
Applicant(s)For all designated states
Novartis AG
Lichtstrasse 35
4056 Basel / CH
[2021/33]
Inventor(s)01 / CAO, Yudong
18 Tonglian Road Riverside Industrial Park
Changshu
Economic Development Zone
Changshu, Jiangsu 215537 / CN
02 / JIANG, Siyi
4218 Jinke Road ZhangJiang Hi-Tech Park
Pudong District
Shanghai 201203 / CN
03 / KIM, Hongyong
No. 18 Tonglian Road Riverside Industrial Park
Changshu
Economic Development Zone
Changshu, Jiangsu 215537 / CN
04 / KORDIKOWSKI, Andreas
Postfach
4002 Basel / CH
05 / XIA, Mei
4218 Jinke Road ZhangJiang Hi-Tech Park,
Pudong District
Shanghai 201203 / CN
06 / YU, Bo
No. 18 Tonglian Road Riverside Industrial Park
Changshu
Economic Development Zone
Changshu, Jiangsu 215537 / CN
07 / ZHANG, Jing
No. 18 Tonglian Road Riverside Industrial Park
Changshu
Economic Development Zone
Changshu, Jiangsu 215537 / CN
08 / ZHAO, Yi
18 Tonglian Road Riverside Industrial Park
Changshu
Economic Development Zone
Changshu, Jiangsu 215537 / CN
 [2024/10]
Former [2021/33]01 / CAO, Yudong
18 Tonglian Road Riverside Industrial Park
Changshu
Economic Development Zone
Changshu, Jiangsu 215537 / CN
02 / JIANG, Siyi
4218 Jinke Road ZhangJiang Hi-Tech Park
Pudong District
Shanghai 201203 / CN
03 / KIM, Hongyong
No. 18 Tonglian Road Riverside Industrial Park
Changshu
Economic Development Zone
Changshu, Jiangsu 215537 / CN
04 / KORDIKOWSKI, Andreas
Postfach
4002 Basel / CH
05 / XIA, Irene
4218 Jinke Road ZhangJiang Hi-Tech Park,
Pudong District
Shanghai 201203 / CN
06 / YU, Bo
No. 18 Tonglian Road Riverside Industrial Park
Changshu
Economic Development Zone
Changshu, Jiangsu 215537 / CN
07 / ZHANG, Jing
No. 18 Tonglian Road Riverside Industrial Park
Changshu
Economic Development Zone
Changshu, Jiangsu 215537 / CN
08 / ZHAO, Yi
18 Tonglian Road Riverside Industrial Park
Changshu
Economic Development Zone
Changshu, Jiangsu 215537 / CN
Representative(s)Ridout, Joseph
Novartis Pharma AG
Patent Department
Lichtstrasse 35
4056 Basel / CH
[N/P]
Former [2021/33]Larbig, Karen Dorothee, et al
Novartis Pharma AG
Patent Department
4002 Basel / CH
Application number, filing date19789751.508.10.2019
[2021/33]
WO2019IB58535
Priority number, dateWO2018CN10941509.10.2018         Original published format: PCT/CN2018/109415
[2021/33]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020075046
Date:16.04.2020
Language:EN
[2020/16]
Type: A1 Application with search report 
No.:EP3864018
Date:18.08.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 16.04.2020 takes the place of the publication of the European patent application.
[2021/33]
Search report(s)International search report - published on:EP16.04.2020
ClassificationIPC:C07D487/04, C07C57/15, A61P33/02, A61K31/519, A61K45/06
[2021/33]
CPC:
C07D487/04 (EP,IL,KR,US); A61K31/519 (EP,IL,KR,US); A61K45/06 (EP,IL,KR,US);
A61K9/0053 (EP,IL,KR); A61P33/02 (EP,IL,KR,US); C07C57/15 (US);
C07B2200/13 (KR,US); Y02A50/30 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/33]
TitleGerman:FESTE FORMEN VON N-(4-FLUOR-3-(6-(3-METHYLPYRIDIN-2-YL)-[1,2,4]-TRIAZOLO[1,5-A]PYRIMIDIN-2-YL)PHENYL)-2,4-DIMETHYLOXAZOL-5-CARBOXAMID[2021/33]
English:SOLID FORMS OF N-(4-FLUORO-3-(6-(3-METHYLPYRIDIN-2-YL)-[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-2-YL)PHENYL)-2,4-DIMETHYLOXAZOLE-5-CARBOXAMIDE[2021/33]
French:FORMES SOLIDES DE N-(4-FLUORO-3-(6-(3-MÉTHYLPYRIDIN-2-YL)-[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-2-YL)PHÉNYL)-2,4-DIMÉTHYLOXAZOLE-5-CARBOXAMIDE[2021/33]
Entry into regional phase10.05.2021National basic fee paid 
10.05.2021Designation fee(s) paid 
10.05.2021Examination fee paid 
Examination procedure15.04.2021Amendment by applicant (claims and/or description)
10.05.2021Examination requested  [2021/33]
10.05.2021Date on which the examining division has become responsible
13.04.2022Invitation to indicate the basis for amendments (Time limit: M01)
21.04.2022Reply to an invitation to indicate the basis for amendments
30.08.2022Despatch of a communication from the examining division (Time limit: M04)
24.10.2022Reply to a communication from the examining division
Fees paidRenewal fee
29.09.2021Renewal fee patent year 03
28.09.2022Renewal fee patent year 04
27.09.2023Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]WO2004078163  (TRANSFORM PHARMACEUTICALS INC [US], et al);
 [Y]WO2007092779  (REDDYS LAB LTD DR [IN], et al);
 [YD]WO2015095477  (IRM LLC [US], et al);
by applicantWO2015095477
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.